About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Texas | 1,335 Studies

Clinical Trials Lung CancerTexas

Lung Cancer Clinical Trials in Texas

Find 1,335 clinical trials for lung cancer near Texas. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1241-1260 of 1,335 trials

CompletedAmifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung CancerRATIONALE: Amifostine may be an effective treatment for the toxic side effects caused by radiation therapy and chemotherapy.NCT00003313·Birmingham, Alabama and 263 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Dose Escalation Trial of PR610 Treating Patients With Solid TumorsThe purpose of this study is to determine the Maximum Tolerated Dose and the Dose-Limiting Toxicity of the drug to further evaluate safety and antitumor activity.NCT01631279·Scottsdale, Arizona and 5 others

CompletedPhase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLCThe investigators propose this phase I/II study to use weekly Nab-Paclitaxel (Abraxane) and carboplatin with concurrent radiation in local-regionally advanced lung cancer.NCT01757288·Rochester, New York and 4 others

RecruitingA Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsThe purpose of the study is to explore the safety and effects of the study drug (PF-08046876) in people diagnosed with advanced cancer of the bladder, lung, head and neck…NCT07090499·Duarte, California and 30 others

TerminatedStereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)The goal of this clinical research study is to compare 2 types of radiotherapy, stereotactic body photon radiotherapy (SBRT) and stereotactic body proton radiotherapy (SBPT).NCT01511081·Houston, Texas

Active not recruitingStudy of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerThis study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that overexpress c-Met (c-Met+) best suited for telisotuzumab vedotin therapy in the…NCT03539536·Mobile, Alabama and 251 others

RecruitingA Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsThis is a first-in-human Phase 1b, 2-part, multicenter open-label clinical study to evaluate safety and efficacy of a Nectin-4 radiopharmaceutical (\[225Ac\]Ac-AKY-1189) in…NCT07020117·Duarte, California and 13 others

TerminatedASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung CancerThe purpose of this study is to determine if adding ASA404 to standard chemotherapy makes the cancer treatment more effective in patients with advanced lung cancer.NCT00662597·Mobile, Alabama and 247 others

RecruitingProspective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung CancerThe objective of this study is to build a prospective cohort in patients with locally advanced or metastatic NSCLC with common EGFR mutations.NCT07028489·Monterey, California and 9 others

CompletedBortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy such as docetaxel use different ways to stop tumor cells from dividing so they stop growing or die.NCT00064012·Birmingham, Alabama and 20 others

CompletedA Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung CancerA Phase 1-2 study of MM-121 in combination with standard therapy for non-small cell lung cancer (NSCLC).NCT00994123·Birmingham, Alabama and 37 others

TerminatedA Safety Study of SGN-CD47M in Patients With Solid TumorsThis trial will study SGN-CD47M to find out whether it is an effective treatment for different types of solid tumors and what side effects (unwanted effects) may occur.NCT03957096·Cleveland, Ohio and 4 others

TerminatedPF-07284892 in Participants With Advanced Solid TumorsThe purpose of this first-in-patient, open label study is to determine the maximum tolerated dose and/or recommended dose for further study of PF-07284892 as a single agent and in…NCT04800822·Phoenix, Arizona and 10 others

TerminatedA Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationThis is a Phase 1 study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of PRT7732 in patients with select advanced or…NCT06560645·San Francisco, California and 27 others

CompletedMAGE A10ᶜ⁷⁹⁶T for Advanced NSCLCThis first time in human study is intended for men and women at least 18 years of age who have advanced lung cancer which has grown or returned after being treated.NCT02592577·Duarte, California and 18 others

UnknownTomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)Tomivosertib combined with pembrolizumab in Subjects with PD-L1 positive NSCLCNCT04622007·Daphne, Alabama and 143 others

CompletedPhase 1/1b Study of MGCD516 in Patients With Advanced CancerMGCD516 is a receptor tyrosine kinase (RTK) inhibitor shown in preclinical models to inhibit a closely related spectrum of RTKs including MET, AXL, MER, and members of the VEGFR…NCT02219711·Birmingham, Alabama and 42 others

TerminatedA Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) ExpressionNon-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung.NCT04274907·Birmingham, Alabama and 38 others

CompletedLung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo LobectomyThe goal of this clinical research study is to evaluate the outcome of a standard radiation treatment called stereotactic radiotherapy (SRT) for NSCLC.NCT02357992·Houston, Texas

CompletedArsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00075426·Galveston, Texas

PreviousPage 63 of 67Next

Other Conditions in Texas

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma